Ketamine therapy

Therapy

What people using Ketamine therapy report

Every report comes from a Lived member, sent anonymously.

Have you tried Ketamine therapy for Treatment-Resistant Depression?

NameHow it went

About Ketamine therapy

How It Works

Ketamine therapy uses low doses of ketamine, a medicine long used for anesthesia, to treat depression that has not improved with other treatments. Standard antidepressants act mainly on serotonin and related brain chemicals and usually take weeks to help. Ketamine works on a different system: it blocks one type of receptor (a docking site on nerve cells) for glutamate, the brain's main chemical for activating nerve cells. In some people, mood improves within hours to days rather than weeks. Exactly why that happens is still being studied. The term covers several different treatments. Esketamine, sold as Spravato, is a nasal spray made from one form of the ketamine molecule. It is approved by the US Food and Drug Administration (FDA) for depression in adults. Ketamine itself is approved only as an anesthetic, so intravenous (IV) ketamine infusions for depression are an off-label use, meaning a doctor prescribes it for a purpose the FDA has not reviewed. Some clinics combine ketamine sessions with talk therapy, an approach called ketamine-assisted psychotherapy (KAP). Compounded ketamine lozenges or tablets for use at home are also sold, often through telehealth companies, and are not FDA-approved for any use.

Who It's For

Ketamine therapy is mainly for adults with major depression that has not responded well to other treatments. This is often called treatment-resistant depression, generally meaning a person has tried at least two antidepressants without enough improvement. Spravato is approved for that situation, used alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for adults with major depression who are having suicidal thoughts or behavior. Ketamine is also promoted for anxiety, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder and chronic pain. The FDA has not found it safe and effective for these uses, and the research behind them is less developed than for depression. Spravato is not approved for children or teenagers. Ketamine is usually avoided or used with extra caution in people with a history of psychosis, a substance use disorder, or certain heart and blood vessel problems.

What It Involves

Treatment starts with an assessment by a psychiatric prescriber, who reviews your mental health history, other medicines, substance use and conditions such as high blood pressure. You may be asked not to eat for about 2 hours beforehand and not to drink for 30 minutes, because nausea is common. With Spravato, you spray the medicine into your own nose in a certified clinic while a healthcare provider watches. Staff check your blood pressure before and after the dose and monitor you for at least 2 hours, until you are judged stable enough to leave. The usual schedule is twice a week for the first 4 weeks, then weekly, then every week or two depending on how well it is working. IV ketamine is given as a slow drip into a vein, often over about 40 minutes, typically in a series of sessions over a few weeks. Clinics set their own schedules and monitoring for IV treatment, so it is worth asking what a clinic checks and for how long. In ketamine-assisted psychotherapy, the dosing is paired with therapy sessions to prepare for and make sense of the experience. You should not drive or operate machinery until the next day, after a restful night's sleep, so you will need someone to take you home. A clinic visit usually takes 2 to 3 hours.

What to Expect

During a session, many people feel detached or dreamlike: sounds and colors may seem more vivid, time may feel distorted, or you may feel as if you are outside your body. Dizziness, numbness, nausea, sleepiness and a temporary rise in blood pressure are also common. The dissociative effects usually fade within a couple of hours, the blood pressure rise can last a few hours, and most people feel like themselves by the next day. Nausea tends to become less frequent over repeated sessions. Some people notice their mood lift within hours or days, but the improvement from a single dose often fades within days to weeks. That is why treatment is given as a course and, for people who benefit, continued at a lower frequency. With Spravato, the prescriber reviews whether it is helping at the end of the first 4 weeks before deciding whether to continue. Progress is usually tracked with depression questionnaires at regular visits. Not everyone responds, and ketamine is normally one part of ongoing care alongside medication, therapy or both.

What the Evidence Says

The strongest evidence is for depression. A Cochrane review of randomized trials found that both ketamine and esketamine may improve depression more than placebo within 24 hours. The evidence for esketamine was of moderate certainty; for ketamine (mostly given by IV) it was low to very low, drawn from smaller trials, and the reviewers noted that it is not yet clear how these results translate into everyday practice. In a large trial of people with treatment-resistant depression, about 27% of those given Spravato reached remission (few or no remaining symptoms) after 8 weeks, compared with about 18% of those given quetiapine, an antipsychotic often added to an antidepressant. In another trial, IV ketamine twice a week worked at least as well as electroconvulsive therapy (ECT), a procedure that uses a brief electrical stimulus to the brain under general anesthesia, for treatment-resistant depression without psychosis. An analysis of 26 trials found that IV ketamine rapidly reduces suicidal thoughts as well as depressive symptoms, but how long these benefits last is not well established. Spravato's own labeling states that it has not been shown to prevent suicide and does not replace hospital care when that is needed. Evidence for at-home compounded ketamine, for ketamine-assisted psychotherapy and for uses beyond depression is much more limited, and the FDA is not aware of evidence that compounded ketamine is safer, more effective or faster than approved treatments.

Risks & Considerations

Ketamine can cause heavy sleepiness, strong dissociation and, rarely, slowed breathing, which is why approved treatment includes monitoring after every dose. It also raises blood pressure for a short time, typically peaking around 40 minutes after a dose. For that reason, esketamine is not used in people with an aneurysm (a bulging, weakened artery), an abnormal tangle of blood vessels called an arteriovenous malformation, or a history of bleeding in the brain. Poorly controlled high blood pressure or heart disease calls for careful review first. Ketamine can be misused, and the risk is higher for people with a history of substance use disorder. Long-term misuse or frequent off-label use has been linked to bladder inflammation, so new urinary pain, urgency or frequency during treatment is worth reporting to your care team. Spravato is not recommended during pregnancy or while breastfeeding, because animal studies suggest possible harm to a developing baby's brain. As with other antidepressants, young adults up to age 24 may have a higher risk of suicidal thoughts and behaviors, so worsening mood or new or stronger suicidal thoughts should be reported to the care team right away. The FDA has warned that compounded ketamine taken at home has no established dosing for mental health conditions and lacks the on-site monitoring that approved treatment requires. Cost and access also matter: Spravato is given only in certified clinics, IV ketamine is off-label and offered mainly by specialty clinics, and every treatment day requires time off and a ride home.

Questions to Ask Your Doctor

  1. 1.Is my depression considered treatment-resistant, and would Spravato or IV ketamine fit my situation better than other options such as a medication change or ECT?
  2. 2.Do my blood pressure, heart history or any past substance use affect whether ketamine is safe for me?
  3. 3.How will we measure whether it is working, and when would we decide to stop or continue?
  4. 4.What monitoring does your clinic provide during and after each session, and what training does the staff have?
  5. 5.Will my insurance cover this treatment, and what will the full course likely cost?

Last reviewed • Oct 2026

Educational content, not medical advice.